Who Is a Candidate for Ozempic for Weight Loss?

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that slows stomach emptying and signals fullness to the brain, reducing hunger and food intake. Not every person is an ideal candidate for this medication, and understanding your individual health profile is the first step toward safe and effective treatment. PlexusDx helps eligible patients across all 50 states access compounded semaglutide injections without insurance, starting at just $189/mo (or $149/mo on the 6-month plan).

BMI and Weight Loss Candidacy for Semaglutide

Body mass index (BMI) is one measure clinicians use to assess whether semaglutide may benefit a patient. Generally, adults with a BMI of 30 or higher (classified as obese) or a BMI of 27 to 29.9 (classified as overweight) with at least one weight-related health condition are considered potential candidates. However, BMI alone does not determine eligibility; your overall metabolic health, medical history, and treatment goals matter equally.

Weight loss with semaglutide typically ranges from 5% to 22% of body weight depending on the individual, adherence, and lifestyle changes. Clinical trials have shown sustained reductions in appetite and caloric intake, which translate into meaningful weight loss when paired with nutrition and activity adjustments. PlexusDx evaluates your personal health profile during the consultation process to confirm whether semaglutide injection aligns with your realistic weight loss objectives.

Medical Conditions That May Support Semaglutide Treatment

Semaglutide candidacy increases if you have type 2 diabetes, high blood pressure, elevated cholesterol, or obstructive sleep apnea—all conditions linked to excess weight and obesity. People with a strong family history of heart disease or metabolic syndrome may also benefit from the blood sugar and blood pressure improvements that sometimes accompany weight loss on GLP-1 therapy. Your personal or family medical history helps PlexusDx determine whether semaglutide injection is a safe and strategically sound option for your health.

Conversely, certain conditions disqualify patients from semaglutide use. Anyone with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or severe pancreatitis should not use GLP-1 medications. Additionally, pregnancy, breastfeeding, and severe kidney or liver disease typically make semaglutide unsuitable. A thorough medical review with PlexusDx ensures you are not at preventable risk.

Age, Medication, and Lifestyle Readiness

Semaglutide is approved for adults 18 and older, but candidacy depends on maturity and commitment to long-term lifestyle change. Teenagers may be considered in specialized circumstances, though most PlexusDx patients are adults seeking sustainable weight management over months or years. Your willingness to track hunger cues, adjust portion sizes, and maintain physical activity dramatically improves outcomes and reduces the risk of weight regain after stopping the medication.

Current medications matter because semaglutide can affect how your body processes other drugs, particularly insulin or diabetes medications. If you take medications for heart disease, blood pressure, or thyroid function, PlexusDx reviews potential interactions during your initial health intake. Patients on stable doses of most common medications can safely use semaglutide with proper monitoring and dose adjustments.

How PlexusDx Personalized Genetic Testing Refines Candidacy

PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that identifies how your body responds to GLP-1 therapy based on key genetic variants. Testing for variants in GIPR and FTO, and MC4R genes reveals whether your genetic makeup predisposes you to strong response, moderate response, or potential challenges with semaglutide. This genetic insight goes beyond traditional BMI and medical history to personalize your weight loss strategy and medication choice.

The Precision Peptide Genetic Test costs $298, allowing you to begin therapy immediately while gathering genetic data that refines your long-term plan. Patients with favorable genetic profiles for GLP-1 response often experience faster appetite suppression and steadier weight loss. PlexusDx uses this genetic map to guide you toward semaglutide injection or alternative compounded formulations, ensuring your treatment is as precise as your biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What BMI do I need to qualify for semaglutide at PlexusDx?

PlexusDx typically considers candidates with a BMI of 30 or higher, or a BMI of 27 to 29.9 with at least one weight-related health condition such as high blood pressure or type 2 diabetes. However, BMI is just one factor; your complete health profile, medications, and weight loss goals are evaluated during your consultation to determine eligibility.

Can I use semaglutide if I have type 2 diabetes?

Yes, semaglutide can be an excellent option for people with type 2 diabetes who are overweight or obese, as it helps lower blood sugar while reducing appetite and supporting weight loss. PlexusDx reviews your current diabetes medications during the intake process to ensure safe dosing and to monitor for any interactions or hypoglycemia risk.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan. Your dose may increase over time as your body adjusts, but your price remains flat—no hidden per-dose charges or membership fees. PlexusDx serves all 50 states without requiring insurance and accepts HSA and FSA funds.

What are the main side effects of semaglutide, and who should avoid it?

Common side effects include nausea, vomiting, constipation, and fatigue, which often improve within days or weeks. You should not use semaglutide if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, pregnancy, or severe pancreatitis. PlexusDx reviews your full medical history to rule out contraindications before treatment begins.

What does the PlexusDx Precision Peptide Genetic Test reveal?

The test identifies genetic variants in GIPR and FTO, and MC4R that influence how your body responds to semaglutide and other GLP-1 therapies. For $298, this peptide-pathway assessment maps 14 metabolic pathways and 49 peptides, revealing whether you are genetically primed for strong semaglutide response or may benefit from a different compounded option.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.